Ayala Pharma: Multiple Milestones Lined Up For The Year
Shares of Ayala Pharmaceuticals Inc. (AYLA) are off 65% from their 52-week high of $28.68, recorded in February of this year, and trade around $10. This clinical-stage oncology company, developing therapeutics for patients suffering from rare and aggressive cancers, made its debut on the NASDAQ Global Market on May 8, 2020, by setting a public offering at $15.00 per share. […]
Read more